FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Lehrstuhl für Innere Medizin I (Medizin 1)
Overview
Publications
(260)
Research Grants
(3)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study (2024)
Suzuki K, Sameshima Y, Yokoyama J, Terai S, Yoneyama H, Atreya R, Neurath M, et al.
Journal article
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024)
Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al.
Journal article
Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience (2024)
Wagner K, Müller T, Vitali F, Fischer S, Haberkamp S, Rouse-Merkel R, Atreya R, et al.
Journal article
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024)
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al.
Journal article
Spatial Single Cell Profiling Using Imaging Mass Cytometry: Inflammatory Versus Penetrating Crohn's Disease (2024)
Lehmann M, Weixler B, Elezkurtaj S, Loddenkemper C, Atreya I, Atreya R, Bacher P, et al.
Journal article
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline (2024)
Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, Germer CT, et al.
Journal article
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024)
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al.
Journal article
Burden of Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Real-World Global Study (2024)
Atreya R, Redondo I, Streit P, Protic M, Hartz S, Gurses G, Knight H, et al.
Journal article
Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in Vivo (2024)
Schramm S, Liu L, Saad M, Dietz L, Dedden M, Müller T, Atreya I, et al.
Journal article
Glowing insights: tracking vedolizumab in the mucosa of patients with IBD via molecular endoscopy (2024)
Atreya R
Journal article
‹
1
2
3
...
26
›